InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (4 ops.)
Insider track record
CEODisclosed buys
0
Disclosed sells
4
T+90 hit rate
0%
T+90 mean return
-57.7%
Across 2 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Discover the complete record of transactions filed by Pierce Robert Hamilton, Executive. Officer active across 1 company, notably Sensei Biotherapeutics, Inc.. In total, 6 disclosures have been published. Breakdown: 0 buy · 4 sells. Total volume traded: €278k. History available since 6 August 2021. The latest transaction was filed on 15 February 2022 (Attribution). Regulator: SEC (Form 4). The full history is openly available.
Declarations6 total
21,000 shares0Common StockSEC:0001209191-22-010982:0
21,000 shares0Common StockSEC:0001209191-22-010982
▼
16,030 shares@ US$7.343636.0% of flowCommon StockSEC:0001209191-21-051172
▼
16,030 shares@ US$7.34360.37% mcap36.0% of flowCommon StockSEC:0001209191-21-051172:0
6,460 shares@ US$7.11270.14% mcap14.0% of flowCommon StockSEC:0001209191-21-050659:0
6,460 shares@ US$7.112714.0% of flowCommon StockSEC:0001209191-21-050659
6 of 6 declarations
About Pierce Robert Hamilton
Robert Hamilton Pierce is the Chief Scientific Officer and Chief R&D Officer at Sensei Biotherapeutics, Inc. He is responsible for leading research and innovation efforts. Robert plays a key role in developing new therapies to address medical needs.
